JAK1 and infection: Finally, infections done in the presence of the JAK1/2 inhibitor ruxolitinib substantially decreased ISG expression for WT CA as well as CA mutants (Fig. 4I through K), suggesting the involvement of the canonical type I IFN pathway upon cGAS-mediated sensing.